Johnson & Johnson

Only slightly more first doses of Pfizer were administered at the FEMA-run vaccination sites on Monday than single-dose Johnson & Johnson shots.

The Johnson & Johnson shots return after federal health officials decided the vaccine’s benefits outweigh a risk of rare blood clots discovered in 15 of nearly 8 million recipients.

State health officials say the CDC is investigating the death of an Oregon woman and hospitalization of another woman in Texas after they received the vaccine.

The European Medicines Agency says a warning about blood clots should be added to labels for Johnson & Johnson’s COVID-19 vaccine.

The sites had been offering the one-dose Johnson & Johnson vaccine until the federal government recommended a pause this past week.

A vast network of professional vaccine skeptics on social media has been waiting for a development like the Johnson & Johnson pause. Now experts say they will milk it for all it's worth and more.

The head of the European Union's executive arm has announced plans for a major contract extension for COVID-19 vaccines with Pfizer.

The president's coronavirus response coordinator says there's more than enough of the Moderna and Pfizer vaccines to continue the pace of 3 million shots per day.

Dr. Vincent Hsu, an epidemiologist and AdventHealth’s infection control officer, discusses the vaccine, complications and why people should still keep getting vaccinated.

Gov. Ron DeSantis called the pause in administering the Johnson & Johnson vaccine a "speed bump," while acknowledging the state would follow the federal recommendation.